Literature DB >> 17505640

[Cardiovascular prevention in diabetic patients: an evidenced-based review].

Mariana Vargas Furtado1, Carisi Anne Polanczyk.   

Abstract

Diabetes mellitus is a condition associated with cardiac complications, especially artherothrombotic disease. Several studies have demonstrated the importance of reducing cardiovascular burden on this population by adopting prevention strategies. This article revised clinical evidences on cardiovascular risk assessment and prevention actions, taking into consideration major recommendations in the field. Life-style changes with low-carbohydrate diet, weight control, and regular physical activity must be implemented. High-risk patients or with established cardiovascular disease ought to have glycemic levels<100 mg/dL and A1c<7%. It is recommended low dose of aspirin and statin for lipid management, targeting LDL<100 mg/dL, HDL>50 mg/dL and tryglycerides<150 mg/dL. Blood pressure control with non-pharmacological and antihypertensive drugs must be instituted, favoring ACE inhibitors as first option, mainly in patients with renal disease, and combined with tiazydes for the majority to achieve target blood pressure of <130/80 mmHg.

Entities:  

Mesh:

Year:  2007        PMID: 17505640     DOI: 10.1590/s0004-27302007000200022

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

Review 1.  The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease.

Authors:  M G S Cavicchioli; C C L Guerbali; C Ochiai; R M Silva; G Camara; T B Z Petry
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113

2.  Impact of diabetes on cardiovascular disease: an update.

Authors:  Alessandra Saldanha de Mattos Matheus; Lucianne Righeti Monteiro Tannus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Carlos Antonio Negrato; Marilia de Brito Gomes
Journal:  Int J Hypertens       Date:  2013-03-04       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.